CAVALIER JASON (Chief Financial Officer) sold 0.1% of their position (769.00 shares) of LYRA THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/8/2026ACC: 0001193125-26-007760
Officer· Chief Financial Officer
Since Sep 2021
-769.00
Net shares
Net seller
$2.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
769.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−769.00
Price / share
$3.36
Trade value
$2.59K
% of position
0.1%
1/6/2026
519.32K→518.55K
Total
Net shares
−769.00
Net value
-$2.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/6/2026 | S · Sale | −769.00 | $3.36 | $2.59K | 0.1% | 519.32K | 518.55K |
| Total | −769.00 | -$2.59K | ||||||
Derivative Transactions0
No derivative transactions reported